Precede Biosciences
Breaking Barriers in Precision Medicine
Boston, United States · Founded 2021
- Headquarters
- Boston
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- precede.bio
About
Precede Biosciences has developed a first-in-class liquid biopsy platform that profiles circulating chromatin and the DNA methylome from just 1mL of plasma. The platform provides genome-wide insight into gene promoters, enhancers, and methylation patterns to reveal disease-defining transcriptional biology. The company partners with drug developers and academic researchers to accelerate precision-medicine development and create blood-based clinical tests as alternatives to invasive tissue biopsies.
Summary
Precede Biosciences is a Biotech company based in Boston, United States, founded in 2021.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...